Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05546814 · ClinicalTrials.gov registry record · NA
Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05546814: Completed NA study, sponsored by Medical College of Wisconsin.
NCT05546814 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05546814, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.
Primary Outcome
To determine the relationship among sodium intake, bodily growth and the gut in preterm infants
Interventions
- PROCEDURE Sodium algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2025-04-14 |
| Phase | NA |
What the finished NCT05546814 record still lists
NCT05546814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Sodium algorithm is the first listed.
NCT05546814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05546814 about?
NCT05546814 is a clinical study titled "Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome". The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.
What is the current status of trial NCT05546814?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-02-08. Estimated completion is 2025-04-14.
What interventions are being tested in trial NCT05546814?
The interventions under investigation include: Sodium algorithm (PROCEDURE).
Who is sponsoring clinical trial NCT05546814?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05546814's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI